Listed

PharmaCyte Biotech, Inc.

PMCBNasdaqCIK 1157075HealthcareFiscal year ends Apr 30

Reports and events: 211 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

PharmaCyte Biotech, Inc., Reports and events
FiledFormWhat it isAccession number
2009-09-1710:53 ET10-QQuarterly reportPeriod 2009-07-310001262463-09-000075
2009-09-1516:53 ET8-K5.02 Departure or appointment of officers or directors0001262463-09-000074
2009-09-1416:46 ET10-QQuarterly reportPeriod 2009-04-300001262463-09-000073
2009-08-1316:05 ET10-KAnnual reportPeriod 2009-04-300001262463-09-000065
2009-04-0616:39 ET8-K/A9.01 Financial statements and exhibits0001262463-09-000030
2009-03-2615:46 ET8-K5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001262463-09-000022
2009-03-1715:04 ET10-QQuarterly reportPeriod 2009-01-310001262463-09-000021
2009-03-0419:06 ET8-K2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity0001262463-09-000019
2009-02-1813:06 ET8-K/A1.01 Entry into a material agreement0001262463-09-000014
2009-02-1709:09 ET8-K1.01 Entry into a material agreement0001262463-09-000012
2009-01-1614:25 ET8-K1.01 Entry into a material agreement0001262463-09-000004

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 20:52 ET. Listed shows no prices and gives no investment advice.